A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of anUSH1Cnonsense mutation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of anUSH1Cnonsense mutation
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 4, Issue 11, Pages 1186-1199
Publisher
EMBO
Online
2012-10-02
DOI
10.1002/emmm.201201438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
- (2011) M. Wilschanski et al. EUROPEAN RESPIRATORY JOURNAL
- PTC124-Mediated Translational Readthrough of a Nonsense Mutation Causing Usher Syndrome Type 1C
- (2011) T. Goldmann et al. HUMAN GENE THERAPY
- Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study
- (2011) Polona Le Quesne Stabej et al. JOURNAL OF MEDICAL GENETICS
- Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
- (2011) Steven M. Rowe et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Post-transcriptionally Regulated Expression System in Human Xenogeneic Transplantation Models
- (2011) Hui-Ling Rose Lee et al. MOLECULAR THERAPY
- Pharmacological Enhancement of ex vivo Gene Therapy Neuroprotection in a Rodent Model of Retinal Degeneration
- (2011) Kevin Gregory-Evans et al. OPHTHALMIC RESEARCH
- Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations
- (2011) Manuela Vecsler et al. PLoS One
- Repairing faulty genes by aminoglycosides: Identification of new pharmacophore with enhanced suppression of disease-causing nonsense mutations
- (2011) Jeyakumar Kandasamy et al. MedChemComm
- Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
- (2010) Isabelle Sermet-Gaudelus et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
- (2010) Igor Nudelman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cellular mechanisms of aminoglycoside ototoxicity
- (2010) Mark E Warchol Current Opinion in Otolaryngology & Head and Neck Surgery
- Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)
- (2010) Richard S. Finkel JOURNAL OF CHILD NEUROLOGY
- Genetics and pathological mechanisms of Usher syndrome
- (2010) Denise Yan et al. JOURNAL OF HUMAN GENETICS
- Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model
- (2010) Cornelia Brendel et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view
- (2010) Jose M. Lopez-Novoa et al. KIDNEY INTERNATIONAL
- Light-dependent translocation of arrestin in rod photoreceptors is signaled through a phospholipase C cascade and requires ATP
- (2009) Wilda Orisme et al. CELLULAR SIGNALLING
- Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
- (2009) Igor Nudelman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa
- (2008) K. Guerin et al. EXPERIMENTAL EYE RESEARCH
- Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease
- (2008) M. Moosajee et al. HUMAN MOLECULAR GENETICS
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- (2008) Eitan Kerem et al. LANCET
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
- (2008) M. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Introducing sense into nonsense in treatments of human genetic diseases
- (2008) Liat Linde et al. TRENDS IN GENETICS
- The translocation of signaling molecules in dark adapting mammalian rod photoreceptor cells is dependent on the cytoskeleton
- (2008) Boris Reidel et al. CELL MOTILITY AND THE CYTOSKELETON
- Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases
- (2007) Mariana Hainrichson et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- SANS (USH1G) expression in developing and mature mammalian retina
- (2007) Nora Overlack et al. VISION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started